Lymphomatoid granulomatosis natural history: Difference between revisions

	Lymphomatoid granulomatosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphomatoid granulomatosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphomatoid granulomatosis natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphomatoid granulomatosis natural history All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphomatoid granulomatosis natural history
CDC on Lymphomatoid granulomatosis natural history
Lymphomatoid granulomatosis natural history in the news
Blogs on Lymphomatoid granulomatosis natural history
Directions to Hospitals Treating Lymphomatoid granulomatosis
Risk calculators and risk factors for Lymphomatoid granulomatosis natural history

VisualWikitext

Revision as of 14:55, 11 December 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Prognosis is generally variable and the 5-year mortality rate of patients with Lymphmatoid granulomatosis is approximately 63-90%. In many instances there is totally remission of the disease

Natural History, Complications, and Prognosis

Natural History

The symptoms of Lymphomatoid granulomatosis usually develop in the fifth to the sixth decade of life, and start with symptoms such as cough, dyspnea , and chest tightness. Patient mostly present with pulmonary symptoms but in 40-50% of cases patients will present with cutaneous symptoms and then 30 present of patients will present with CNS

symptoms.

Complications

Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]

Prognosis

Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good

References

Template:WH Template:WS

@@ Line 5: / Line 5: @@
 ==Overview==
-If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
+Prognosis is generally variable and the 5-year mortality rate of patients with Lymphmatoid granulomatosis is approximately 63-90%. In many instances there is totally remission of the disease
-OR
-Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
-OR
-Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
 ==Natural History, Complications, and Prognosis==
 ===Natural History===
-*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
+The symptoms of Lymphomatoid granulomatosis usually develop in the fifth to the sixth decade of life, and start with symptoms such as cough, dyspnea , and chest tightness. Patient mostly present with pulmonary symptoms but in 40-50% of cases patients will present with cutaneous symptoms and then 30 present of patients will present with CNS
-*The symptoms of (disease name) typically develop ___ years after exposure to ___.
+ symptoms.
-*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
 ===Complications===
@@ Line 28: / Line 19: @@
 ===Prognosis===
-*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
+Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good
-*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
-*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
-*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
-*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
 ==References==
 {{Reflist|2}}